Medicament for topical application
CA 2372929 C · Owner: Bio-Products & Bio-Engineering Aktiengesellschaft · Inventors: Eibl, Johann
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a medicament for topical application for the purpose of stopping , bleedings and/or closing wounds and/or promoting wound healing which as , active substances , - produced conventionally of allogenic plasma or tissue or recombinantly - contains , fibrinogen or fibrin, thrombin and one or several transglutaminase(s) wherein , the , medicament, as a further active substance contains one or several protease , inhibitor(s) selected from the group consisting of serpins that do not have inhibiting effects on , collagenases and elastases all of the active substances being of allogenic origin and having , been subjected to a process for virus depletion and/or virus …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 19, 2000 and granted November 15, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.